Lemerond Nicole 4
4 · InMed Pharmaceuticals Inc. · Filed Aug 10, 2022
Insider Transaction Report
Form 4
Lemerond Nicole
Director
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-08-10+14,000→ 14,000 totalExercise: $0.39Exp: 2027-08-10→ Common shares (14,000 underlying)
Footnotes (1)
- [F1]The options were granted on Aug 10, 2022 and will vest monthly, in arrears, as follows: (i) 390 stock options will vest on the 10th day of each month for 35 months, and (ii) 350 stock options will vest on Aug 10, 2025 (the three year anniversary of Grant date).